Prospects for reform of the IND/NDA processes: part II.
D002986:Clinical Trials as Topic / Q000379:methods*; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration